Skip to main content

Profile

Close
nermeen

Nermeen Varawalla MBA’00D

President of the UK National Alumni Association

Contact

Additional Information

Nermeen is a business leader in the Healthcare & Life Sciences sectors with expertise in drug development. Her portfolio includes Chief Medical Officer at Scancell Ltd developing therapeutic cancer vaccines, Chair at Crism Therapeutics focused on oncology drug delivery, Chair of Atorvia Health Technologies with a lead asset for kidney failure, Board Member, Oxford India Centre, University of Oxford and Board of Governors, University of Hertfordshire to provide guidance for the set-up of its new medical school. Also, Nermeen is President of the UK INSEAD Alumni Association and the Alumni Association of Somerville College, University of Oxford.

Nermeen completed her medical training at the University of Mumbai, before receiving a Rhodes Fellowship for her doctorate at Oxford University following which she worked as an NHS obstetrician and gynaecologist. After an MBA at INSEAD, Nermeen transitioned to business by joining Accenture’s Strategy Consulting Practice.

Recognising the opportunity to conduct global clinical trials in India, Nermeen founded a pioneering business which she sold to PRA Health Sciences (now ICON plc) and proceeded to hold leadership roles in the contract research business. Notably Nermeen raised private equity financing to build ECCRO, which she exited to join the Intas Pharmaceutical Group. Following this transition Nermeen has held leadership roles at several biopharmaceutical and medical technology companies including BTG International plc. until it’s acquisition by Boston Scientific Corporation, Atlantic Healthcare and Relief Therapeutics. In addition, she has served as a Trustee Board Member for the Malaria Consortium.